Funder: Gilead Sciences
Due Dates (Anticipated): September 2027 (Application deadline, projected)
Funding Amounts: Award size and duration vary by project scope, scale, and country; up to 10% of budget may be dedicated to impact reporting.
Summary: Supports global (excluding US) community initiatives to enhance education, awareness, and action to eliminate viral hepatitis as a public health threat by 2030.